FARALLON CAPITAL MANAGEMENT LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$19.7B
Holdings
292
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (292 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | FIVNFIVE9 INC | 116,000 | $18.5B | 93.88% | |
| 102 | RCREADY CAPITAL CORP | 1,250,226 | $18.0B | 91.40% | |
| 103 | —POINT BIOPHARMA GLOBAL INC | 2,290,000 | $17.6B | 89.22% | |
| 104 | NVV1NOVAVAX INC | 83,713 | $17.4B | 87.92% | |
| 105 | FVAVFORTRESS VALUE ACQUISI CORP | 1,750,000 | $17.0B | 86.35% | |
| 106 | —MERCURY ECOM ACQUISITION COR | 1,732,500 | $16.9B | 85.49% | |
| 107 | —SHELTER ACQUISITION CORP I | 1,650,000 | $16.0B | 81.25% | |
| 108 | —BIG SKY GROWTH PARTNERS INC | 1,550,000 | $15.2B | 76.80% | |
| 109 | SRPTSAREPTA THERAPEUTICS INC | 162,000 | $15.0B | 75.90% | |
| 110 | FGENEURFIBROGEN INC | 1,446,212 | $14.8B | 74.88% | |
| 111 | —AUSTERLITZ ACQUISITION CORP II | 1,500,000 | $14.6B | 74.09% | |
| 112 | —KKR ACQUISITION HOLDING I CO | 1,500,000 | $14.6B | 74.09% | |
| 113 | —ZEALAND PHARMA A/S | 510,000 | $14.3B | 72.48% | |
| 114 | RCELAVITA MEDICAL INC | 800,000 | $14.2B | 71.82% | |
| 115 | —DISRUPTIVE ACQUISITION CORP | 1,400,000 | $13.6B | 68.87% | |
| 116 | YMMFULL TRUCK ALLIANCE CO LTD | 815,000 | $12.5B | 63.30% | |
| 117 | —FOREST ROAD ACQUISITION COR | 1,250,000 | $12.2B | 61.75% | |
| 118 | —AGILE GROWTH CORP | 1,200,000 | $11.7B | 59.09% | |
| 119 | —TIGA ACQUISITION CORP | 1,080,000 | $10.9B | 55.42% | |
| 120 | —GORES METROPOULOS II INC | 1,100,000 | $10.9B | 55.06% | |
| 121 | —FS DEVELOPMENT CORP II | 1,000,000 | $9.9B | 50.41% | |
| 122 | —CASCADE ACQUISITION CORP | 990,000 | $9.9B | 49.91% | |
| 123 | —FIFTH WALL ACQUISITN CORP III | 1,000,000 | $9.8B | 49.75% | |
| 124 | —FORUM MERGER IV CORP | 1,000,000 | $9.8B | 49.45% | |
| 125 | —ARES ACQUISITION CORPORATION | 1,000,000 | $9.7B | 49.34% | |
| 126 | —TAILWIND TWO ACQUISITION COR | 1,000,000 | $9.7B | 49.29% | |
| 127 | —CORAZON CAPITAL V838 MONOCER | 1,000,000 | $9.7B | 49.27% | |
| 128 | CCIXCHURCHILL CAPITAL CORP VII | 1,000,000 | $9.7B | 49.24% | |
| 129 | —VIRGIN GROUP ACQUISIT CORP I | 1,000,000 | $9.7B | 49.19% | |
| 130 | QUREUNIQURE NV | 300,000 | $9.6B | 48.65% | |
| 131 | YB4PSAVARA INC | 6,512,086 | $9.0B | 45.53% | |
| 132 | VCYTVERACYTE INC | 185,222 | $8.6B | 43.59% | |
| 133 | JOYY 1.375 06/15/26JOYY INC | 9,000,000 | $8.4B | 42.59% | |
| 134 | QSIQUANTUM SI INC | 1,000,000 | $8.3B | 42.25% | |
| 135 | —ARYA SCIENCES ACQU CORP IV | 800,000 | $8.0B | 40.77% | |
| 136 | KCAC-UNKENSINGTON CAPITAL ACQUISITI | 775,200 | $7.9B | 40.06% | |
| 137 | —LEVERE HOLDINGS CORP | 800,000 | $7.8B | 39.56% | |
| 138 | JWSMFJAWS MUSTANG ACQUISITION COR | 800,000 | $7.8B | 39.56% | |
| 139 | —POST HOLDINGS PARTNERING COR | 800,000 | $7.7B | 39.07% | |
| 140 | SURFUSDSURFACE ONCOLOGY INC | 1,000,000 | $7.6B | 38.35% | |
| 141 | —REINVENT TECHNOLOGY PARTNERS | 750,000 | $7.4B | 37.73% | |
| 142 | —CM LIFE SCIENCES III INC | 750,000 | $7.4B | 37.69% | |
| 143 | —PATHFINDER ACQUISITION CORP | 750,000 | $7.4B | 37.54% | |
| 144 | DRIOEURDARIOHEALTH CORP | 540,000 | $7.4B | 37.34% | |
| 145 | —WARBURG PINCUS CAPTAL CORP I A | 750,000 | $7.4B | 37.31% | |
| 146 | —ARYA SCIENCES ACQUISITN CORP V | 745,000 | $7.4B | 37.29% | |
| 147 | —TPG PACE BENEFICIAL II CORP | 750,000 | $7.4B | 37.29% | |
| 148 | —CATALYST PARTNRS ACQUISITN C | 753,900 | $7.4B | 37.24% | |
| 149 | —SOCIAL LEVERAGE ACQUISN CORP | 750,000 | $7.3B | 37.16% | |
| 150 | —GORES HOLDINGS VII INC | 750,000 | $7.3B | 37.16% | |
| 151 | —WARBURG PINCUS CAPTAL CORP I B | 750,000 | $7.3B | 37.16% | |
| 152 | —APOLLO STRATEGIC GRWT CPTL II | 750,000 | $7.3B | 37.12% | |
| 153 | —ARCLIGHT CLEAN TRANSITION II | 750,000 | $7.3B | 37.08% | |
| 154 | —THUNDER BRIDGE CAP PRTNRS III | 750,000 | $7.3B | 37.08% | |
| 155 | —RESEARCH ALLIANCE CORP II | 750,000 | $7.3B | 37.06% | |
| 156 | —PANACEA ACQUISITION CORP II | 750,000 | $7.3B | 37.05% | |
| 157 | —VECTOR ACQUISITION CORP II | 750,000 | $7.3B | 37.05% | |
| 158 | —LONGBOARD PHARMACEUTICALS IN | 810,500 | $7.2B | 36.34% | |
| 159 | —NOVUS CAPITAL CORPORATION II | 710,451 | $7.0B | 35.63% | |
| 160 | —KHOSLA VENTURES ACQUISITION | 700,000 | $6.9B | 35.00% | |
| 161 | —CORSAIR PARTNERING CORP | 700,000 | $6.9B | 34.93% | |
| 162 | —SUPERNOVA PARTN ACQ CO III L | 700,000 | $6.8B | 34.43% | |
| 163 | CCXIEURCHEMOCENTRYX INC | 386,000 | $6.6B | 33.44% | |
| 164 | —RADIUS HEALTH INC | 6,783,000 | $6.0B | 30.39% | |
| 165 | —VPC IMPACT ACQU HOLDI III IN | 600,000 | $5.9B | 30.12% | |
| 166 | —GORES TECHNOLOGY PARTNERS II | 600,000 | $5.9B | 29.73% | |
| 167 | —RXR ACQUISITION CORP | 600,000 | $5.8B | 29.55% | |
| 168 | —FINSERV ACQUISITION CORP II | 600,000 | $5.8B | 29.52% | |
| 169 | —INTERPRIVATE IV INFRATECH PR | 600,000 | $5.8B | 29.47% | |
| 170 | —BLUE WHALE ACQUISITION CORP | 575,000 | $5.8B | 29.16% | |
| 171 | —NEXTGEN ACQUISITION CORP II | 550,914 | $5.5B | 27.66% | |
| 172 | BCABBIOATLA INC | 180,000 | $5.3B | 26.85% | |
| 173 | COGTCOGENT BIOSCIENCES INC | 600,000 | $5.0B | 25.56% | |
| 174 | —HUMANCO ACQUISITION CORP | 508,900 | $5.0B | 25.50% | |
| 175 | BEKEKE HLDGS INC | 273,000 | $5.0B | 25.25% | |
| 176 | —G SQUARED ASCEND I INC | 500,000 | $4.9B | 24.99% | |
| 177 | —TCV ACQUISITION CORP | 500,000 | $4.9B | 24.82% | |
| 178 | —COLONNADE ACQUISITION CORP I | 500,000 | $4.9B | 24.77% | |
| 179 | —ROCKET INTERNET GRWT OPRT CO | 500,000 | $4.9B | 24.75% | |
| 180 | —FTAC HERA ACQUISITION CORP | 500,000 | $4.9B | 24.67% | |
| 181 | —LANDCADIA HOLDINGS IV INC | 500,000 | $4.9B | 24.67% | |
| 182 | —TIO TECH A | 500,000 | $4.8B | 24.55% | |
| 183 | —SCION TECH GROWTH II | 450,000 | $4.4B | 22.23% | |
| 184 | —VPC IMPACT ACQUISITION HLDG II | 425,000 | $4.2B | 21.21% | |
| 185 | —AVROBIO INC | 740,000 | $4.1B | 20.92% | |
| 186 | —INTERPRIVATE III FINANCIAL P | 400,000 | $4.0B | 20.07% | |
| 187 | —FIRST RESERVE SUSTAINABLE GW | 400,000 | $4.0B | 20.06% | |
| 188 | —GORES HLDGS VIII INC | 400,000 | $3.9B | 19.90% | |
| 189 | —INTERPRIVATE II ACQUISITION | 400,000 | $3.9B | 19.82% | |
| 190 | —NIGHTDRAGON ACQUISITION CORP | 400,000 | $3.9B | 19.80% | |
| 191 | CCIXCHURCHILL CAPITAL CORP VI | 400,000 | $3.9B | 19.80% | |
| 192 | TNGXTANGO THERAPEUTICS INC | 300,000 | $3.9B | 19.65% | |
| 193 | —TPG PACE SOLUTIONS CORP | 350,000 | $3.5B | 17.82% | |
| 194 | 698ACHILLES THERAPEUTICS PLC | 450,000 | $3.5B | 17.76% | |
| 195 | —LONGVIEW ACQUISITION CORP II | 304,698 | $3.0B | 15.26% | |
| 196 | —LAZARD GROWTH ACQUISITION CO | 300,000 | $2.9B | 14.79% | |
| 197 | —NORTHERN GENESIS ACQUISITION | 278,026 | $2.8B | 13.99% | |
| 198 | —GORES TECHNOLOGY PARTNERS IN | 250,000 | $2.5B | 12.44% | |
| 199 | —DRAGONEER GROWTH OPT CORP II | 250,000 | $2.5B | 12.41% | |
| 200 | —SVF INVESTMENT CORP | 250,000 | $2.4B | 12.36% |